Radical Prostatectomy With and Without Neoadjuvant Chemohormonal Pretreatment for High-Risk Localized Prostate Cancer: A Comparative Propensity Score Matched Analysis
Shintaro Narita(Akita University), Tomonori Habuchi(Akita University), Sadafumi Kawamura(Miyagi Prefectural Hospital Organization), Kazuyuki Numakura(Akita University), Norihiko Tsuchiya(Yamagata University), Takuya Koie(Hirosaki University), Shigeru Satoh(Kyoto Prefectural University), Takamitsu Inoue(International University of Health and Welfare), Koji Mitsuzuka(Pacific Northwest Diabetes Research Institute), Hiroshi Nanjo(Akita University), Mitsuru Saito(Jikei University School of Medicine), Chikara Οhyama(Hirosaki University), Yoichi Arai(Japan Atomic Energy Agency), Taketoshi Nara(Akita University), Tatsuo Tochigi(Miyagi Prefectural Hospital Organization), Sohei Kanda(Akita University)
Cited by 24
Related Papers
Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial
|The Lancet Oncology|2017|1.8k
Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma
|New England Journal of Medicine|2020|1.5k
Prospective Randomized Phase II Trial of a Single Early Intravesical Instillation of Pirarubicin (THP) in the Prevention of Bladder Recurrence After Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma: The THP Monotherapy Study Group Trial
|Journal of Clinical Oncology|2013|253